Skip to content
10-K

Annual Report

ProKidney Corp. PROK

0001193125-26-113881

← back to feed
Filed
Mar 18, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Stock Repurchased FY 2025 · Dec 31, 2025 $0
Stock Repurchased FY 2025 · Dec 31, 2024 $0
Stock Repurchased FY 2025 · Dec 31, 2023 $9.5M
Capex FY 2025 · Dec 31, 2025 $15.2M
Capex FY 2025 · Dec 31, 2024 $29.51M
Capex FY 2025 · Dec 31, 2023 $34.2M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$120.12M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$126.35M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$90.07M
Cash And Equivalents FY 2025 · Dec 31, 2025 $108.54M
Cash And Equivalents FY 2025 · Dec 31, 2024 $99.12M
Stockholders Equity FY 2025 · Dec 31, 2025 −$1.01B
Stockholders Equity FY 2025 · Dec 31, 2024 −$994.95M
Stockholders Equity FY 2025 · Dec 31, 2023 −$1.1B
Stockholders Equity FY 2025 · Dec 31, 2022 −$1.1B
Current Liabilities FY 2025 · Dec 31, 2025 $30.74M
Current Liabilities FY 2025 · Dec 31, 2024 $36.22M
Total Liabilities FY 2025 · Dec 31, 2025 $34.78M
Total Liabilities FY 2025 · Dec 31, 2024 $39.44M
Current Assets FY 2025 · Dec 31, 2025 $280.68M
Current Assets FY 2025 · Dec 31, 2024 $395.88M
Total Assets FY 2025 · Dec 31, 2025 $335.57M
Total Assets FY 2025 · Dec 31, 2024 $441.07M
Sga Expense FY 2025 · Dec 31, 2025 $51.78M
Sga Expense FY 2025 · Dec 31, 2024 $56.08M
Sga Expense FY 2025 · Dec 31, 2023 $44.82M
Rd Expense FY 2025 · Dec 31, 2025 $114.12M
Rd Expense FY 2025 · Dec 31, 2024 $127.67M
Rd Expense FY 2025 · Dec 31, 2023 $106.71M
Net Income FY 2025 · Dec 31, 2025 −$68.99M
Net Income FY 2025 · Dec 31, 2024 −$61.19M
Net Income FY 2025 · Dec 31, 2023 −$35.47M
Operating Income FY 2025 · Dec 31, 2025 −$165.01M
Operating Income FY 2025 · Dec 31, 2024 −$183.68M
Operating Income FY 2025 · Dec 31, 2023 −$151.52M
Revenue FY 2025 · Dec 31, 2025 $893K
Revenue FY 2025 · Dec 31, 2024 $76K
Revenue FY 2025 · Dec 31, 2023 $0